GPR155 and gastric cancer: These clinicopathological analyses support the hypothesis that GPR155 is specifically associated with hematogenous metastasis of GC and that detecting reduced levels of GPR155 mRNA in primary GC tissue is useful for the diagnosis of synchronous hematogenous metastasis as well as for determining a patient’s risk of hematogenous recurrence after curative gastrectomy.